Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Blood|May 6, 2006
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitorBlanca Sanchez-Gonzalez, Hui Yang, Carlos Bueso-Ramos, et al.
Journal of Medical Economics|May 17, 2012
The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsAnnie Guérin, Eric Q Wu, Vamsi K Bollu, et al.
Blood|June 10, 2011
Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cellsMin Tang, Mithat Gonen, Alfonso Quintas-Cardama, et al.
Haematologica|January 25, 2012
Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapyNaveen Pemmaraju, Hagop Kantarjian, Jianqin Shan, et al.
Cancer|September 7, 2006
Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemiaAlfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, et al.
Blood|August 2, 2011
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitorsElias Jabbour, Hagop Kantarjian, Susan O'Brien, et al.
Blood|August 18, 2011
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignanciesDushyant Verma, Hagop Kantarjian, Sara S Strom, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 12, 2011
The clinical significance of achieving different levels of cytogenetic response in patients with chronic phase chronic myeloid leukemia after failure to front-line therapy: is complete cytogenetic response the only desirable endpoint?Jorge Cortes, Alfonso Quintas-Cardama, Elias Jabbour, et al.
Leukemia Research|July 30, 2013
Modest activity of pomalidomide in patients with myelofibrosis and significant anemiaNaval Daver, Aditi Shastri, Tapan Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 25, 2013
Similar outcome of patients with chronic myeloid leukemia treated with imatinib in or out of clinical trialsMusa Yilmaz, Hagop Kantarjian, Elias Jabbour, et al.
Pageof 4